Oscar del Brutto

Regresar

Oscar del Brutto-Investigación-Centro de Investigaciones UEES


Es Director, de Proyecto Atahualpa Project, Atahualpa, Ecuador (2012 al momento), Profesor de Neurología, Facultad de Medicina, Universidad Espíritu Santo – Ecuador (2012 al momento), Neurólogo del Departamento de Ciencias Neurológicas, Hospital-Clínica Kennedy, Guayaquil, Ecuador (1989 al momento).

Dirección
Hospital-Clínica Kennedy, Sección Delta, Oficina S-7, Calle 9na s/n y Avenida San Jorge, Guayaquil, Ecuador; y Centro de Investigación, Universidad Espíritu Santo – Ecuador, Km 3, Vía Puntilla-Samborondón, Ecuador

Educación
Doctor en Medicina y Cirugía (M.D.), Facultad de medicina, Universidad Católica de Santiago de Guayaquil (1976-1984).

Especialista en neurología, Universidad Nacional Autónoma de México (1989).

Residencia de Neurología, Instituto nacional de Neurología y Neurocirugía de México (1986-1989).

Lineas de investigación
Salud.

Regresar

Ponencias

  1. Platform presentation: Lateral pontine hemorrhages. IX Annual Meeting of the Mexican Academy of Neurology, Guadalajara, Mexico, November 1986.
  2. Platform presentation: Ataxic hemiparesis from cysticercosis. XI Annual Meeting of the Mexican Academy of Neurology, Chihuahua, Mexico, November 1987.
  3. Platform presentation: Neurocysticercose en pays d’endemie (Mexique): interet de l’IRM. Annual Meeting of the French Society of Neuroradiology, Paris, France, December 1987.
  4. Poster presentation: MHC restriction mechanisms of immune response in human neurocysticercosis. XIV Annual Meeting of the American Society for Histocompatibility and Immunogenetics, San Francisco, CA, USA, October 1988.
  5. Platform presentation: MR imaging of intracranial tuberculoma: comparison with CT. XXIII Latinoamerican Congress of Neurosurgery, Acapulco, Mexico, November 1988.
  6. Platform presentation: Intracranial tuberculomas: analysis of 37 patients. XII Annual Meeting of the Mexican Academy of Neurology, Zacatecas, Mexico, November 1988.
  7. Platform presentation: Lacunar syndromes due to neurocysticercosis. XII Annual Meeting of the Mexican Academy of Neurology, Zacatecas, Mexico, November 1988.
  8. Platform presentation: Brainstem Tuberculomas. IV Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1989.
  9. Platform presentation: Therapeutic regimen of anticysticercal drugs in patients with parenchymal neurocysticercosis. IV Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1989.
  10. Platform presentation: Occlusion of the middle cerebral artery due to cysticercotic angiitis. IV Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1989.
  11. Poster presentation: Epilepsy due to neurocysticercosis: analysis of 203 patients. 43rd Annual Meeting of the American Academy of Neurology, Boston, MA, USA, April 1991.
  12. Platform presentation: Late-onset epilepsy in Ecuador. V Ecuadorian Congress of Neurology, Quito, Ecuador, May 1991.
  13. Platform presentation: Tropical spastic paraparesis in Ecuador. V Ecuadorian Congress of Neurology, Quito, Ecuador, May 1991.
  14. Platform presentation: Albendazole therapy for giant subarachnoid cysticercus. I Ecuadorian Congress of Neurosurgery, Guayaquil, Ecuador, November 1991.
  15. Poster presentation: Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with benign prognosis. 45th Annual Meeting of the American Academy of Neurology, Washington, DC, USA, May 1993.
  16. Platform presentation: Single enhancing CT lesions. VI Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1993.
  17. Platform presentation: Stroke subtypes among hispanics living in Guayaquil, VI Ecuadorian Congress of Neurology, Guayaquil, May 1993.
  18. Poster presentation: Takayasu’s disease: analysis of seven patients. XVII Sudamerican Congress of Cardiology, Cartagena de Indias, Colombia, August 1995.
  19. Platform presentation: Ischemic cerebrovascular complications of Takayasu’s disease. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  20. Platform presentation: Angiographic findings in Ecuadorian mestizos with anterior circulation occlusive cerebrovascular disease. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  21. Platform presentation: Primary intraventricular hemorrhage: analysis of prognostic factors in 25 patients. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  22. Poster presentation: Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 15 patients. 48th Annual Meeting of the American Academy of Neurology, San Francisco, CA, USA, March 1996.
  23. Poster presentation: Nontraumatic intracerebral hemorrhage in young adults: Analysis of 151 patients. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  24. Poster presentation: Dolichoectatic vertebrobasilar artery: Review of 27 cases. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  25. Poster presentation: History of human cysticercosis. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  26. Poster presentation: Pontine hemorrhages: analysis of 52 patients. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  27. Poster presentation: Cerebellar hemorrhages. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  28. Poster presentation: Angiographic findings in Ecuadorian mestizos with anterior circulation occlusive cerebrovascular disease. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  29. Poster presentation: Intracranial hemorrhages in primary tumors of the central nervous system: analysis of prognostic factors in 14 patients. XXVIII Latinamerican Congress of Neurosurgery, Santiago de Chile, Chile, October 1998
  30. Platform presentation: Pontine hemorrhage: analysis of prognostic factors in 51 patients. XX Congress of Medicine, Surgery, and Specialities, Luis Vernaza Hospital, Guayaquil, Ecuador, November 1998
  31. Poster presentation: Primary intraventricular hemorrhages. 51th Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 1999.
  32. Poster presentation: Cerebrovascular complications of snake bites. V Congress of the Iberoamerican Society of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  33. Poster presentation: Are lacunar strokes different in hispanic patients? The SPS3 study. 18th European Stroke Conference, Stockholm, Sweden, May 2009.
  34. Poster presentation: Profile of 7519 neurologic outpatients in Guayaquil, Ecuador. 64th Annual Meeting of the American Academy of Neurology, New Orleans, US, April 2012
  35. Poster presentation: calcified neurocysticercosis among patients with primary headache. 64th Annual Meeting of the American Academy of Neurology, New Orleans, US, April 2012
  36. Poster presentation: Subjective sleep quality and insomnia: correlation with cardiovascular health status in community-dwelling elders living in rural coastal Ecuador – The Atahualpa Project. 66th Annual Meeting of the American Academy of Neurology, Philadelphia, US, April 2014
  37. Poster presentation: Comparing cognitive screening tools in a rural Ecuadorian population: The Atahualpa Project. 66th Annual Meeting of the American Academy of Neurology, Philadelphia, US, April 2014
  38. Poster presentation: cerebral microbleeds. 67th Annual Meeting of the American Academy of Neurology, Washington DC, US, April 2015
  39. Poster presentation: feasibility of sleep studies in developing countries. 67th Annual Meeting of the American Academy of Neurology, Washington DC, US, April 2015

Profesor Invitado A Congresos (Conferencias Magistrales)

  1. Therapy of neurocysticercosis. Course Update on Neurocysticercosis, National Institute of Neurology and Neurosurgery of Mexico, Mexico DF, Mexico, March 1988.
  2. Diagnosis and treatment of neurocysticercosis. 1st Congress of Medicine and Surgery of the Gustavo Baz Hospital, Netzahualcoyotl, Mexico, October 1988.
  3. 1st Course of Neuropsychology of the Mexican Society of Audiology, Mexico DF, Mexico, November 1988.
  4. XXVIII National Congress of Surgeons Mexico DF, Mexico, November 1988.
  5. V Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1991.
  6. Tropical Spastic Paraparesis, XIV Annual Meeting of the Association of Physicians of the National Institute of Neurology and Neurosurgery of Mexico, Acapulco, Mexico, December 1991.
  7. Angiitis of the central nervous system. VI Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1993.
  8. Management of Neurocysticercosis. IV International Course of Neuropediatric, Quito, Ecuador, July 1993.
  9. Recent advances in the treatment of neurocysticercosis. XVI Annual Meeting of the Association of Physicians of the National Institute of Neurology and Neurosurgery of Mexico, Mazatlan, Mexico, September 1993.
  10. Epilepsy due to neurocysticercosis. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  11. Cysticercosis: importance as a cause of morbidity and current concepts of clinical management. Informal consultation of cysticercosis, sponsored by the P.A.H.O. Brasilia, Brazil, August 1995.
  12. Cysticercosis and epilepsy. IX Panamerican Congress of Neurology, Guatemala city, Guatemala, October 1995.
  13. Diagnostic criteria for cysticercosis. 48th Annual Meeting of the American Academy of Neurology, San Francisco, CA, USA, March 1996.
  14. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. I International Symposium on Cysticercosis, Lima, Perú, May 1996.
  15. Cysticercosis in the acute encephalitic phase. I International Symposium on Cysticercosis, Lima, Perú, May 1996.
  16. Epilepsy due to neurocysticercosis. I International Symposium on Cysticercosis, Lima, Perú, May 1996.
  17. Epidemiology of stroke in Hispanics. Presented before the Stroke team of the Department of Neurology, University of Texas at Houston, Houston, TX, USA, June 1996.
  18. Grands Rounds of the University of Texas at Houston, Houston, TX, USA, June 1996.
  19. Cysticercosis in Ecuadorian children. 2nd International Symposium of Neurocysticercosis in Childhood “Tanya Martinez Flisser”, México city, México, August 1996.
  20. Control of Taeniosis/Cysticercosis in Ecuador. 2nd International Symposium of Neurocysticercosis in Childhood “Tanya Martinez Flisser”, México city, México, August 1996.
  21. Recent advances in the diagnosis and management of neurocysticercosis. Presented at the Symposium: Neurocysticercosis an emerging public health problem, Sponsored by the CDC and NIH, Boston, MA, USA, April 1997.
  22. Diagnostic criteria for cysticercosis. VIII Ecuadorian Congress of Neurology, Guayaquil, Ecuador, July 1997.
  23. How to write a scientific paper. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  24. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  25. Differential diagnosis of vascular dementia. International Course on Alzheimer’s Disease. Pamplona, Spain, November 1997.
  26. Intracranial hemorrhages in young adults. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  27. Racial differences in stroke subtypes. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  28. Infections of the nervous system. XX Congress of Medicine, Surgery, and Specialities, Luis Vernaza Hospital, Guayaquil, Ecuador, November 1998
  29. How to write a paper. Presented before the National Institute of Neurology and Neurosurgery of Mexico, Mexico D.F., Mexico, February 1999.
  30. Presentation, diagnosis, subtypes and diagnostic criteria for cysticercosis. Symposium Cysticercosis and Epilepsy presented by the University of Southern California School of Medicine, Glendale, CA, USA, May 1999.
  31. Medical therapy for cysticercosis: albendazole and praziquantel. Symposium Cysticercosis and Epilepsy presented by the University of Southern California School of Medicine, Glendale, CA, USA, May 1999.
  32. Controversies of treatment and the development of a treatment algorithm for cysticercosis. Symposium Cysticercosis and Epilepsy presented by the University of Southern California School of Medicine, Glendale, CA, USA, May 1999.
  33. Stroke in South America. II Iberoamerican Congress of Cerebrovascular Disease, Mexico City, Mexico, September 1999.
  34. Infections and stroke. II Iberoamerican Congress of Cerebrovascular Disease, Mexico City, Mexico, September 1999.
  35. Therapy of neurocysticercosis. X Panamerican Congress of Neurology, Cartagena de Indias, Colombia, October 1999
  36. Cerebrovascular complications of infectious diseases: X Panamerican Congress of Neurology, Cartagena de Indias, Colombia, October 1999.
  37. Peruvian Congress of Neurology, Lima, Perú, November 1999.
  38. Present and future of cerebrovascular disease in the Americas, III Iberoamerican Congress of Cerebrovascular Disease, La Habana, Cuba, September 2000.
  39. Tropical causes of stroke. III Iberoamerican Congress of Cerebrovascular Disease, La Habana, Cuba, September 2000.
  40. N Presented before the Dominican Society of Neurology. Santo Domingo, Dominican Republic, November 2000.
  41. Medical publications in Spanish. IX Course in Spanish of the American Academy of Neurology, Miami, Fl, USA, November 2000.
  42. Diagnosis of neurocysticercosis. 49th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Houston, TX, USA, November 2000.
  43. 53rd Annual Meeting of the American Academy of Neurology, Philadelphia, PA, USA, May 2001.
  44. Infections and stroke. X European Stroke Conference. Lisbon, Portugal, May 2001
  45. XVII World Congress of Neurology, London, England, June 2001.
  46. XIII Colombian Congress of Neurology, Cartagena, Colombia, October 2001.
  47. Cerebrovascular complications of infectious diseases. XXIII International Meeting of Internal Medicine, Lima, Perú, October 2001.
  48. Classification and management of intracranial hemorrhages. XXIII International Meeting of Internal Medicine, Lima, Perú, October 2001.
  49. XXIII International Meeting of Internal Medicine, Lima, Perú, October 2001.
  50. Neurological complications of infective endocarditis. Ecuadorian Congress of Cardiology, Guayaquil, Ecuador, October 2001.
  51. Intracranial hemorrhages: classification and management. IV Iberoamerican Congress of Cerebrovascular Disease. San Pedro Sula, Honduras, November 2001
  52. The ischemic penumbra. IV Iberoamerican Congress of Cerebrovascular Disease. San Pedro Sula, Honduras, November 2001.
  53. Grand Rounds of the University of Texas at San Antonio, San Antonio, TX, USA, January 2002.
  54. Cysticercosis and other parasitic diseases of the nervous system. 54th Annual Meeting of the American Academy of Neurology, Denver, CO, USA, April 2002.
  55. Neuroimaging findings in neurocysticercosis. WHO Symposium of Taeniosis/cysticercosis in Africa, Arusha, Tanzania, August 2002.
  56. Neurocysticercosis, VIII International Course of Neurosciences of the National Institute of Neurological Sciences Oscar Trelles Montes, Lima, Perú, August 2002
  57. Cerebrovascular complications of infective endocarditis. V Iberoamerican Congress of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  58. Tropical causes of cerebrovascular disease. V Iberoamerican Congress of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  59. Proposal for a multicentric neuroepidemiological stroke study in Latin America, V Iberoamerican Congress of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  60. Treatment of Diabetic Neuropathy. VI Ecuadorian Congress of Nephrology, Guayaquil, Ecuador, October 2002.
  61. How to publish medical papers in Spanish. X Course in Spanish of the American Academy of Neurology, San Juan, Puerto Rico, November 2002.
  62. Neuropathology of cysticercosis. I Workshop on Brain Calcifications and Epileptogenesis of the National Institute of Neurological Sciences Oscar Trelles Montes, Lima, Perú, February 2003
  63. Helminthic infections of the nervous system. 55th Annual Meeting of the American Academy of Neurology, Honolulu, Hawaii, USA, April 2003.
  64. Cysticercosis and Chagas’ disease. 55th Annual Meeting of the American Academy of Neurology, Honolulu, Hawaii, USA, April 2003.
  65. Emerging stroke risk factors. XII European Stroke Conference, Valencia, Spain, May 2003.
  66. Neurocysticercosis, VIII Peruvian Congress of Infectious and Tropical Diseases, Lima, Perú, August 2003
  67. Treatment of intracranial hemorrhages. VI Iberoamerican Congress of Cerebrovascular Disease, San José, Costa Rica, September 2003.
  68. Stroke in South America, VI Iberoamerican Congress of Cerebrovascular Disease, San José, Costa Rica, September 2003
  69. XI Panamerican Congress of Neurology, Santiago de Chile, Chile, October 2003.
  70. Non pharmacological neuroprotection in patients with acute ischemic stroke. XI Panamerican Congress of Neurology, Santiago de Chile, Chile, October 2003.
  71. Stroke in South America. XI Panamerican Congress of Neurology, Santiago de Chile, Chile, October 2003.
  72. Cerebrovascular complications of neurocysticercosis. 52th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA, USA, November 2003.
  73. Helminthic infections of the nervous system. 56th Annual Meeting of the American Academy of Neurology, San Francisco, CA, USA, April 2004.
  74. The magnitude of stroke in Latin America. V World Stroke Congreess, Vancouver, Canada, June 2004.
  75. Therapy of intracranial hemorrhage. Ecuadorian Congress of Neurosurgery. Guayaquil, Ecuador. September 2004.
  76. Comunity studies of stroke in Latin America. VII Iberoamerican Congress of Cerebrovascular Diseases, Cancún, Mexico, September 2004.
  77. Cerebral ischemia in subarachnoid hemorrhage and in intracerebral hemorrhage. Mechanisms and therapeutic approaches. XIV European Stroke Conference, Bolonia, Italy, May 2005.
  78. Parasiticidal effect and associated inflammation. Workshop Advances in Cysticercosis of the National Institute of Neurological Sciences Oscar Trelles Montes. Lima, Peru, June 2005
  79. What evidence exists that anti-inflammatory agents decrease symptoms in neurocysticercosis. Workshop Advances in Cysticercosis of the National Institute of Neurological Sciences Oscar Trelles Montes. Lima, Peru, June 2005
  80. Advances in the management of subarachnoid cysticercosis. XI Resident Meeting of the National Institute of Neurological Sciences Oscar Trelles Montes. Lima, Peru, June 2005
  81. Albendazole and praziquantel for therapy of neurocysticercosis: a meta-analysis of randomized, controlled trials. XII Ecuadorian Congress of Neurology, Salinas, Ecuador, July 2005.
  82. The role of the Institutional review board in medical investigation. XII Ecuadorian Congress of Neurology, Salinas, Ecuador, July 2005.
  83. Neurocysticercosis and stroke. XVIII World Congress of Neurology, Sydney, Australia, November 2005.
  84. Neuroimaging of infectious diseases of the nervous system. XVIII World Congress of Neurology, Sydney, Australia, November 2005.
  85. Parasitic infections. 58th Annual Meeting of the American Academy of Neurology, San Diego, CA, USA, April 2006.
  86. Infectious causes of stroke in different geographical areas. XV European Stroke Conference, Brussels, Belgium, May 2006.
  87. Epiediomology of Stroke in Latin America. IX Iberoamerican Congress of Cerebrovascular Diseases, Guatemala City. Guatemala, September 2006
  88. Infectious endocarditis. X Iberoamerican Congress of Cerebrovascular Disease, Lima, Perù, September 2007.
  89. The Challenges of conducting a clinical trial in developing countries. Annual Meeting of SPS3 investigators. San Diego, CA, September 2007.
  90. Annual Meeting of the Infectious Disease Society of North America, San Diego, CA, October 2007
  91. Neuroimaging of infections and stroke. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  92. Parasitic diseases of the nervous system. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  93. Treatment of neurocysticercosis. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  94. Small vessel disease. Epidemiology and risk factors. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  95. Tropical causes of stroke. 60th Annual Meeting of the American Academy of Neurology. Chicago, Ill, April 2008
  96. Neurocysticercosis and other parasitic infections. 60th Annual Meeting of the American Academy of Neurology. Chicago, Ill, April 2008.
  97. Infections and stroke. XX European Stroke Conference, Hamburg, Germany, May 2011.
  98. Is lacunar disease a different disease in Latin America? XXI European Stroke Conference, Lisbon, Portugal, May 2012.
  99. Neurocysticercosis and stroke. VIII World Stroke Congress, Brasilia, Brazil, October 2012.
  100. Infections and stroke. VIII World Stroke Congress, Brasilia, Brazil, October 2012.
  101. Tropical epilepsy. 65th Annual Meeting of the American Academy of Neurology, San Diego, US, April 2013
  102. Neurocysticercosis in non-endemic areas and in the traveler. 65th Annual Meeting of the American Academy of Neurology, San Diego, US, April 2013
  103. Neurocysticercosis and epilepsy. 66th Annual Meeting of the American Academy of Neurology, Philadelphia, US, April 2014
  104. Neurocysticercosis and epilepsy. Grand Rounds University of Loyola, April 2015.

Admisiones 2019

Ingresar